PRIMA-1MET cytotoxic effect correlates with p53 protein reduction in TP53-mutated chronic lymphocytic leukemia cells-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

PRIMA-1MET cytotoxic effect correlates with p53 protein reduction in TP53-mutated chronic lymphocytic leukemia cells

Published:2020-02 Issue: Volume:89 Page:106288
ISSN:0145-2126
Container-title:Leukemia Research
language:en
Short-container-title:Leukemia Research

Author:

Jaskova Zuzana,Pavlova Sarka,Malcikova Jitka,Brychtova Yvona,Trbusek Martin

Funder

Specific University Research Project

Ministry of Education, Youth and Sports

inistry of Health of the Czech Republic.

Publisher

Elsevier BV

Subject

Cancer Research,Oncology,Hematology

Reference51 articles.

1. The mutational landscape of chronic lymphocytic leukemia and its impact on prognosis and treatment;Gaidano;Hematology,2017

2. Frontline therapy of CLL: evolving treatment paradigm;Boddy;Curr. Hematol. Malig. Rep.,2018

3. Single-agent ibrutinib in treatment-naïve and relapsed/refractory chronic lymphocytic leukemia: a 5-year experience;O’Brien;Blood,2018

4. Evaluation of 230 patients with relapsed/refractory deletion 17p chronic lymphocytic leukaemia treated with ibrutinib from 3 clinical trials;Jones;Br. J. Haematol.,2018

5. Blinded by the light: the growing complexity of p53;Vousden;Cell,2009

Cited by 5 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Targeting mutant p53 stabilization for cancer therapy;Frontiers in Pharmacology;2023-07-12

2. Duplication of 8q24 in Chronic Lymphocytic Leukemia: Cytogenetic and Molecular Biologic Analysis of MYC Aberrations;Frontiers in Oncology;2022-06-24

3. Targeting the p53 Pathway in CLL: State of the Art and Future Perspectives;Cancers;2021-09-18

4. Antitumor Effects of PRIMA-1 and PRIMA-1Met (APR246) in Hematological Malignancies: Still a Mutant P53-Dependent Affair?;Cells;2021-01-07

5. Targeting p53 in chronic lymphocytic leukemia;Expert Opinion on Therapeutic Targets;2020-10-19

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3